Evidence map›Paper›PMID 20843307›Full record

ArticleMolecular cancer2010

Epstein-Barr virus-encoded EBNA1 enhances RNA polymerase III-dependent EBER expression through induction of EBER-associated cellular transcription factors.

Thomas J Owen, John D O'Neil, Christopher W Dawson, Chunfang Hu, Xiaoyi Chen, Yunhong Yao, Victoria H J Wood, Louise E Mitchell, Robert J White, Lawrence S Young and 1 more

Open access · goldAbstract read
In one paragraph

Article in Molecular cancer, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 27 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Thomas J OwenSchool of Cancer Sciences, University of Birmingham, Birmingham, UK.
John D O'Neil
Christopher W Dawson
Chunfang Hu
Xiaoyi Chen
Yunhong Yao
Victoria H J Wood
Louise E Mitchell
Robert J White
Lawrence S Young
John R Arrand
University of Birmingham · GBCancer Research UK Scotland Institute · GBGuangdong Medical College · CN

Funding

Cancer Research UK
6 · The paper itself

Abstract

backgroundEpstein-Barr Virus (EBV)-encoded RNAs (EBERs) are non-polyadenylated RNA molecules transcribed from the EBV genome by RNA polymerase III (pol III). EBERs are the most abundant viral latent gene products, although the precise mechanisms by which EBV is able to achieve such high levels of EBER expression are not fully understood. Previously EBV has been demonstrated to induce transcription factors associated with EBER expression, including pol III transcription factors and ATF-2. We have recently demonstrated that EBV-encoded nuclear antigen-1 (EBNA1) induces cellular transcription factors, and given these findings, we investigated the role of EBNA1 in induction of EBER-associated transcription factors.

resultsOur data confirm that in epithelial cells EBNA1 can enhance cellular pol III transcription. Transient expression of EBNA1 in Ad/AH cells stably expressing the EBERs led to induction of both EBER1 and EBER2 and conversely, expression of a dominant negative EBNA1 led to reduced EBER expression in EBV-infected Ad/AH cells. EBNA1 can induce transcription factors used by EBER genes, including TFIIIC, ATF-2 and c-Myc. A variant chromatin precipitation procedure showed that EBNA1 is associated with the promoters of these genes but not with the promoters of pol III-transcribed genes, including the EBERs themselves. Using shRNA knock-down, we confirm the significance of both ATF-2 and c-Myc in EBER expression. Further, functional induction of a c-Myc fusion protein led to increased EBER expression, providing c-Myc binding sites upstream of EBER1 were intact. In vivo studies confirm elevated levels of the 102 kD subunit of TFIIIC in the tumour cells of EBV-positive nasopharyngeal carcinoma biopsies.

conclusionsOur findings reveal that EBNA1 is able to enhance EBER expression through induction of cellular transcription factors and add to the repertoire of EBNA1's transcription-regulatory properties.

Indexed as

Activating Transcription Factor 2Cell Line, TumorChromatin ImmunoprecipitationEpstein-Barr Virus Nuclear AntigensFluorescent Antibody TechniqueHumansImmunoblottingImmunohistochemistryOligonucleotide Array Sequence AnalysisProto-Oncogene Proteins c-mycReverse Transcriptase Polymerase Chain ReactionRNA Polymerase IIIRNA, ViralTranscription FactorsTranscription Factors, TFIIITranscription Factor TFIIICActivating Transcription Factor 2Epstein-Barr virus encoded RNA 1Epstein-Barr virus encoded RNA 2Epstein-Barr Virus Nuclear AntigensMYC protein, humanProto-Oncogene Proteins c-mycRNA Polymerase IIIRNA, ViralTranscription FactorsTranscription Factors, TFIIITranscription Factor TFIIIC

Identifiers

PMID20843307
PMCPMC2945964
OpenAlexW2163324118

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.